UK markets close in 11 minutes
  • FTSE 100

    7,584.19
    +72.19 (+0.96%)
     
  • FTSE 250

    19,169.53
    -16.63 (-0.09%)
     
  • AIM

    847.37
    +3.15 (+0.37%)
     
  • GBP/EUR

    1.1561
    -0.0006 (-0.06%)
     
  • GBP/USD

    1.1922
    -0.0028 (-0.24%)
     
  • BTC-GBP

    14,159.84
    +360.19 (+2.61%)
     
  • CMC Crypto 200

    400.70
    +0.01 (+0.00%)
     
  • S&P 500

    3,951.64
    -5.99 (-0.15%)
     
  • DOW

    33,692.05
    -160.48 (-0.47%)
     
  • CRUDE OIL

    80.23
    +2.03 (+2.60%)
     
  • GOLD FUTURES

    1,766.60
    +2.90 (+0.16%)
     
  • NIKKEI 225

    27,968.99
    -58.85 (-0.21%)
     
  • HANG SENG

    18,597.23
    +392.55 (+2.16%)
     
  • DAX

    14,371.95
    +16.50 (+0.11%)
     
  • CAC 40

    6,724.80
    +55.83 (+0.84%)
     

The past five years for SCYNEXIS (NASDAQ:SCYX) investors has not been profitable

Some stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss. Spare a thought for those who held SCYNEXIS, Inc. (NASDAQ:SCYX) for five whole years - as the share price tanked 90%. We also note that the stock has performed poorly over the last year, with the share price down 76%. Furthermore, it's down 53% in about a quarter. That's not much fun for holders. We really hope anyone holding through that price crash has a diversified portfolio. Even when you lose money, you don't have to lose the lesson.

So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress.

See our latest analysis for SCYNEXIS

SCYNEXIS isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. When a company doesn't make profits, we'd generally expect to see good revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

In the last half decade, SCYNEXIS saw its revenue increase by 76% per year. That's well above most other pre-profit companies. So on the face of it we're really surprised to see the share price has averaged a fall of 14% each year, in the same time period. You'd have to assume the market is worried that profits won't come soon enough. While there might be an opportunity here, you'd want to take a close look at the balance sheet strength.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

earnings-and-revenue-growth
earnings-and-revenue-growth

It's good to see that there was some significant insider buying in the last three months. That's a positive. On the other hand, we think the revenue and earnings trends are much more meaningful measures of the business. So we recommend checking out this free report showing consensus forecasts

A Different Perspective

While the broader market lost about 19% in the twelve months, SCYNEXIS shareholders did even worse, losing 76%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 14% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. It's always interesting to track share price performance over the longer term. But to understand SCYNEXIS better, we need to consider many other factors. Like risks, for instance. Every company has them, and we've spotted 5 warning signs for SCYNEXIS (of which 1 is a bit concerning!) you should know about.

SCYNEXIS is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.